The safety profile of transcatheter edge-to-edge repair (TEER) of the mitral valve for degenerative mitral regurgitation (MR) was excellent, with a high rate of successful TEER that increased over 8 years in an older patient population, according to an analysis of the real-world Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapy (TVT) Registry.